164 related articles for article (PubMed ID: 6942429)
1. Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.
Major PP; Egan EM; Beardsley GP; Minden MD; Kufe DW
Proc Natl Acad Sci U S A; 1981 May; 78(5):3235-9. PubMed ID: 6942429
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
Grant S; Bhalla K; Rauscher F; Cadman E
Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
[TBL] [Abstract][Full Text] [Related]
3. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
Kufe DW; Weichselbaum R; Egan EM; Dahlberg W; Fram RJ
Mol Pharmacol; 1984 Mar; 25(2):322-6. PubMed ID: 6700578
[TBL] [Abstract][Full Text] [Related]
4. Correlation of cytotoxicity with incorporation of ara-C into DNA.
Kufe DW; Major PP; Egan EM; Beardsley GP
J Biol Chem; 1980 Oct; 255(19):8997-900. PubMed ID: 7410404
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D
Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
[TBL] [Abstract][Full Text] [Related]
6. Detection of 1-beta-D-arabinofuranosylcytosine incorporation into DNA in vivo.
Spriggs D; Robbins G; Ohno Y; Kufe D
Cancer Res; 1987 Dec; 47(24 Pt 1):6532-6. PubMed ID: 3479246
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
Bhalla K; Nayak R; Grant S
Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
[TBL] [Abstract][Full Text] [Related]
8. Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cells.
Kufe D; Spriggs D; Egan EM; Munroe D
Blood; 1984 Jul; 64(1):54-8. PubMed ID: 6587917
[TBL] [Abstract][Full Text] [Related]
9. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
Karp JE; Donehower RC; Dole GB; Burke PJ
Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163
[TBL] [Abstract][Full Text] [Related]
10. Effects of cis-diamminedichloroplatinum on DNA incorporation and cytotoxicity of 1-beta-D-arabinofuranosylcytosine.
Spriggs DR; Robbins G; Kufe DW
Biochem Pharmacol; 1986 Dec; 35(23):4297-302. PubMed ID: 3790154
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
Ross DD; Chen SR; Cuddy DP
Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
[TBL] [Abstract][Full Text] [Related]
12. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
Lauzon GJ; Paterson AR; Belch AW
Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
Kufe D; Herrick D; Crumpacker C; Schnipper L
Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.
Ross DD; Cuddy DP; Cohen N; Hensley DR
Cancer Chemother Pharmacol; 1992; 31(1):61-70. PubMed ID: 1458561
[TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
Ross DD; Akman SA; Joneckis CC; Yang E; Bachur NR
Cancer Res; 1984 Apr; 44(4):1530-5. PubMed ID: 6584206
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors.
Grant S; Rauscher F; Cadman E
Cancer Res; 1982 Oct; 42(10):4007-13. PubMed ID: 6955007
[TBL] [Abstract][Full Text] [Related]
17. Cellular and clinical pharmacology of low-dose ara-C.
Kufe DW; Griffin JD; Spriggs DR
Semin Oncol; 1985 Jun; 12(2 Suppl 3):200-7. PubMed ID: 3925558
[TBL] [Abstract][Full Text] [Related]
18. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
19. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
Vilpo JA; Vilpo LM
Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
[TBL] [Abstract][Full Text] [Related]
20. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
Lauzon GJ; Paran JH; Paterson AR
Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
